Histological Assessment of the Sclerotic Graft-versus-Host Response in the Humanized RAG2-/-γc-/- Mouse Model

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 7, 2012, Pages 1023-1035

  Hogenes, Marieke C H ^a   van Dorp, Suzanne ^a   van Kuik, Joyce ^a   Monteiro, Filipa R P ^a   ter Hoeve, Natalie ^a   van Dijk, Marijke R ^a   Martens, Anton C ^a   de Weger, Roel A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Graft versus host disease; Histology; Migration patterns; Mouse model

Indexed keywords

MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL INFILTRATION; CELL INTERACTION; CELL MIGRATION; CELL POPULATION; CELL TRANSPLANTATION; CONTROLLED STUDY; FIBROSIS; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HEART; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTESTINE; KIDNEY; LIVER; LUNG; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA CELL; REGULATORY T LYMPHOCYTE; SKIN; SPLEEN; T LYMPHOCYTE; WHOLE BODY RADIATION;

ANIMALS; BLOOD VESSELS; CELL MOVEMENT; CYTOKINES; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; SCLEROSIS; TRANSPLANTATION, HETEROLOGOUS; WHOLE-BODY IRRADIATION;

EID: 84862154105     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.05.002     Document Type: Article

References (56)

1. Farag S.S. Chronic graft-versus-host disease: where do we go from here?. Bone Marrow Transplant 2004, 33:569-577.
2. Ferrara J., Antin J. The pathophysiology of graft-vs-host disease. Thomas' Hematopoietic Cell Transplantation 2004, 353-368. Blackwell Science, Malden, MA. K.G. Blume (Ed.).
3. Lee S.J. New approaches for preventing and treating chronic graft-versus-host disease. Blood 2005, 105:4200-4206.
4. Canninga-van Dijk M.R., van der Straaten H.M., Fijnheer R., et al. Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease. Blood 2004, 104:2603-2606.
5. Dazzi F., Marelli-Berg F.M. Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells. Eur J Immunol 2008, 38:1479-1482.
6. Liotta F., Frosali F., Querci V., et al. Human immature myeloid dendritic cells trigger a TH2-polarizing program via Jagged-1/Notch interaction. J Allergy Clin Immunol 2008, 121:1000-1005.
7. + T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 2005, 90:516-525.
8. Ramasamy R., Tong C.K., Seow H.F., et al. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. Cell Immunol 2008, 251:131-136.
9. Shimabukuro-Vornhagen A., Hallek M.J., Storb R.F., et al. The role of B cells in the pathogenesis of graft-versus-host disease. Blood 2009, 114:4919-4927.
10. + T cells and macrophages: communication between two regulators of effector T cells. Inflamm Res 2008, 57:564-570.
11. Berney T., Molano R.D., Pileggi A., et al. Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes. Transplantation 2001, 72:133-140.
12. Goldman J.P., Blundell M.P., Lopes L., et al. Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br J Haematol 1998, 103:335-342.
13. Lubin I., Segall H., Marcus H., et al. Engraftment of human peripheral blood lymphocytes in normal strains of mice. Blood 1994, 83:2368-2381.
14. Mosier D.E., Gulizia R.J., Baird S.M., et al. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988, 335:256-259.
15. -/- double-mutant mice. Blood 2003, 102:2522-2531.
16. null mice. Blood 2005, 106:1565-1573.
17. McCune J.M., Namikawa R., Kaneshima H., et al. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988, 241:1632-1639.
18. McDermott SP, Eppert K, Lechman ER, et al. Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood. XXXX;116:193-200.
19. null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005, 174:6477-6489.
20. Tary-Lehmann M., Saxon A., Lehmann P.V. The human immune system in hu-PBL-SCID mice. Immunol Today 1995, 16:529-533.
21. Ito R., Katano I., Kawai K., et al. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice. Transplantation 2009, 87:1654-1658.
22. King M.A., Covassin L., Brehm M.A., et al. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor γ chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 2009, 157:104-118.
23. null mice. Exp Hematol 2007, 35:1823-1838.
24. Hesselton R.M., Koup R.A., Cromwell M.A., et al. Human peripheral blood xenografts in the SCID mouse: characterization of immunologic reconstitution. J Infect Dis 1993, 168:630-640.
25. Hoffmann-Fezer G., Gall C., Zengerle U., et al. Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice. Blood 1993, 81:3440-3448.
26. Weijer K., Uittenbogaart C.H., Voordouw A., et al. Intrathymic and extrathymic development of human plasmacytoid dendritic cell precursors in vivo. Blood 2002, 99:2752-2759.
27. Hagemeijer M.C., van Oosterhout M.F., van Wichen D.F., et al. T cells in cardiac allograft vasculopathy are skewed to memory Th-1 cells in the presence of a distinct Th-2 population. Am J Transplant 2008, 8:1040-1050.
28. -/- double-knockout mice. Transfusion 2006, 46:1553-1560.
29. Schroeder MA, DiPersio JF Mouse models of graft-versus-host disease: advances and limitations. Dis Model Mech 2011, 4:318-333.
30. Claman H.N., Jaffee B.D., Huff J.C., et al. Chronic graft-versus-host disease as a model for scleroderma, II: mast cell depletion with deposition of immunoglobulins in the skin and fibrosis. Cell Immunol 1985, 94:73-84.
31. Howell C.D., Yoder T., Claman H.N., et al. Hepatic homing of mononuclear inflammatory cells isolated during murine chronic graft-vs-host disease. J Immunol 1989, 143:476-483.
32. McCormick L.L., Zhang Y., Tootell E., et al. Anti-TGF-β treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol 1999, 163:5693-5699.
33. Chu Y.W., Gress R.E. Murine models of chronic graft-versus-host disease: insights and unresolved issues. Biol Blood Marrow Transplant 2008, 14:365-378.
34. Contassot E., Murphy W., Angonin R., et al. In vivo alloreactive potential of ex vivo-expanded primary T lymphocytes. Transplantation 1998, 65:1365-1370.
35. Ferrara J.L. Cytokines and the regulation of tolerance. J Clin Invest 2000, 105:1043-1044.
36. Favre A., Cerri A., Bacigalupo A., et al. Immunohistochemical study of skin lesions in acute and chronic graft-versus-host disease following bone marrow transplantation. Am J Surg Pathol 1997, 21:23-34.
37. + cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa. Blood 2009, 113:3620-3630.
38. Dickinson A.M., Sviland L., Dunn J., et al. Demonstration of direct involvement of cytokines in graft-versus-host reactions using an in vitro human skin explant model. Bone Marrow Transplant 1991, 7:209-216.
39. Sawamura S.A., Tanaka K., Noda S., et al. The role of intestinal bacterial flora in the tuning of the T cell repertoire. Immunobiology 1999, 201:120-132.
40. Wolff D., Reichenberger F., Steiner B., et al. Progressive interstitial fibrosis of the lung in sclerodermoid chronic graft-versus-host disease. Bone Marrow Transplant 2002, 29:357-360.
41. Akpek G., Boitnott J.K., Lee L.A., et al. Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. Blood 2002, 100:3903-3907.
42. Andersen C.B., Horn T., Sehested M., et al. Graft-versus-host disease: liver morphology and pheno/genotypes of inflammatory cells and target cells in sex-mismatched allogeneic bone marrow transplant patients. Transplant Proc 1993, 25(1 Pt 2):1250-1254.
43. Yeh K.H., Hsieh H.C., Tang J.L., et al. Severe isolated acute hepatic graft-versus-host disease with vanishing bile duct syndrome. Bone Marrow Transplant 1994, 14:319-321.
44. Deeg H.J. Cytokines in graft-versus-host disease and the graft-versus-leukemia reaction. Int J Hematol 2001, 74:26-32.
45. Ihn H., Yamane K., Kubo M., et al. Blockade of endogenous transforming growth factor β signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor β receptors. Arthritis Rheum 2001, 44:474-480.
46. Kubo M., Ihn H., Yamane K., et al. Up-regulated expression of transforming growth factor β receptors in dermal fibroblasts in skin sections from patients with localized scleroderma. Arthritis Rheum 2001, 44:731-734.
47. Del Galdo F., Jimenez S.A. T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro. Arthritis Rheum 2007, 56:3478-3488.
48. Zhang Y., McCormick L.L., Gilliam A.C. Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. J Invest Dermatol 2003, 121:713-719.
49. Igarashi A., Nashiro K., Kikuchi K., et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 1996, 106:729-733.
50. Igarashi A., Nashiro K., Kikuchi K., et al. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 1995, 105:280-284.
51. Wu JM, Thoburn CJ, Wisell J, et al. CD20, AIF-1, and TGF-β in graft-versus-host disease: a study of mRNA expression in histologically matched skin biopsies. Mod Pathol 2010, 23:720-728.
52. Murphy W.J., Welniak L.A., Taub D.D., et al. Differential effects of the absence of interferon-γ and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest 1998, 102:1742-1748.
53. del Rosario M.L., Zucali J.R., Kao K.J. Prevention of graft-versus-host disease by induction of immune tolerance with ultraviolet B-irradiated leukocytes in H-2 disparate bone marrow donor. Blood 1999, 93:3558-3564.
54. Brok H.P., Vossen J.M., Heidt P.J. IFN-γ-mediated prevention of graft-versus-host disease: pharmacodynamic studies and influence on proliferative capacity of chimeric spleen cells. Bone Marrow Transplant 1998, 22:1005-1010.
55. Yang Y.G., Sergio J.J., Pearson D.A., et al. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Blood 1997, 90:4651-4660.
56. Yi T., Rao D.A., Tang P.C., et al. Amelioration of human allograft arterial injury by atorvastatin or simvastatin correlates with reduction of interferon-γ production by infiltrating T cells. Transplantation 2008, 86:719-727.